News | March 06, 2009

Siemens Adds 16-Slice Biograph TruePoint PET/CT System

March 6, 2008 – Siemens expands is imaging portfolio with the addition of the Biograph TruePoint 16-slice PET/CT imager, a Works in Progress (WIP) pending 510k approval, in order to offer affordable access to high-quality imaging.

The Biograph TruePoint PET/CT imaging family includes High-Definition PET/CT and now expands its offering with 16-slice CT capabilities. The Biograph TruePoint 16-slice PET/CT will be highlighted this week at the European Congress of Radiology, March 6-10, in Vienna, Austria.

”The introduction of this particular system is critical as we continue to search for the balance between innovation and access. The likelihood that universal adoption of PET/CT technology will increase with accessibility is a shared industry vision. As an industry leader, it is our responsibility to make that vision more readily attainable,” said Michael Reitermann, CEO, Molecular Imaging, Siemens Healthcare. “The Biograph TruePoint 16-slice PET•CT is a means to achieve that end, with high performance technology housed in an economical package.”

As the U.S. and international economies struggle to increase the quality of patient care and, simultaneously, reduce healthcare costs, Biograph TruePoint 16-slice PET/CT represents a viable solution for healthcare providers. Offering an affordable and reliable imaging system with high-performance capabilities, the 16-slice Biograph PET/CT offers features, such as High-Definition PET and routine 10-minute, whole-body imaging.

The system is built for patient comfort and reflects features of the Siemens flagship Biograph mCT model. It is equipped with a 500-pound (227 kg) capacity patient bed and efficient workflow system. The system offers faster scan speeds at lower patient doses; important when patients need multiple scans for oncology treatment planning and follow-up.

The complete Biograph family of PET/CT imagers now offers options in TruePoint PET/CT for 6-, 16-, 40- and 64-slice CT configurations, as well as the Biograph mCT technology platform with 40-, 64- and 128-CT slice capabilities. The expanding Biograph family of imagers continues to be a comprehensive portfolio of solutions with upgrade possibilities and non-obsolescence protection. The new Biograph 16-slice PET/CT system is also mobile-ready, equipped to maximize on-location patient throughput with fast, 10-minute imaging.

The Biograph 16-slice PET/CT offers 2 mm uniform PET resolution throughout the field of view and a two-time improvement in signal-to-noise ratio, which provides for small lesion detection. Fast scanning and low patient radiation dose is accomplished through Siemens TrueV extended PET field of view. Providers can achieve scans at twice the scan speed or half the patient dose.

Siemens’ industry-leading dose protection, Care Dose 4D, is also included with Biograph TruePoint systems. With advanced imaging tools, the Biograph 16-slice PET•CT system offers an affordable and reliable imaging solution that can satisfy the needs of an institution of any size, and is able to grow at the same rate as clinical requirements dictate.

*This product is a Works in Progress (WIP) pending 510k approval and is not yet commercially available in the U.S. This product does not yet fulfill all the essential requirements according to the European Medical Device Directive (93/42/EEC) and its national implementations. It is not yet commercially available in the European Union.

Related Content

SNMMI Publishes New FDG PET/CT Appropriate Use Criteria
News | PET-CT | October 25, 2017
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG PET/...
Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
Toshiba Highlights Latest CT Advancements at RSNA 2017
News | Computed Tomography (CT) | September 18, 2017
Toshiba Medical announced that it will display several new enhancements to its existing computed tomography (CT)...
Double Targeting Ligands to Identify and Treat Prostate Cancer

The mice were imaged with small-animal PET/CT using 124I-RPS-027 (7.4 MBq [200 μCi]). Credit: JM Kelly et al., Department of Radiology, Weill Cornell Medicine, New York, NY

News | Prostate Cancer | September 14, 2017
Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while...
Blue Earth Diagnostics Announcing Results of FALCON PET/CT Trial at ASTRO 2017
News | PET-CT | September 13, 2017
September 13, 2017 — Blue Earth Diagnostics announced the upcoming oral presentation of initial results from the FALC
FDG-PET/CT Predicts Melanoma Patients' Response to Immune Checkpoint Inhibitor Therapy
News | PET-CT | September 07, 2017
September 7, 2017 — Advanced melanoma has a poor prognosis, but immune checkpoint inhibitor therapy can be effective
Videos | Nuclear Imaging | August 24, 2017
Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and p
ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging | August 18, 2017
August 18, 2017 — The American Society of Nuclear Cardiology (ASNC) has released a joint expert consensus document wi
PET/CT Tracer Identifies Vulnerable Lesions in Non-Small Cell Lung Cancer Patients

Example of a patient with an upper left lung NSCLC: A: FDG; B: FDG PET/CT; C: Planning radiotherapy based on FDG (66Gy) with BTVm (GTV), CTV and PTV; D: PET FMISO E: FMISO PET/CT; F: boost based on the FMISO PET (76Gy) with BTVh (biological hypoxic target volume) and PTV boost. Credit: QuantIF – LITIS EA 4108 – FR CNRS 3638, Henri Becquerel Cancer Center, Rouen, France

News | PET-CT | July 14, 2017
July 14, 2017 — Fluorine-18 (18F)-fluoromisonidazole (FMISO) is a positron emission tomography (PET)...
Overlay Init